Julie Cardoso: FDA Clears the First AI-Guided Ultrasound Software for Suspected DVT
Julie Cardoso, Owner and Executive Director of Independent Diagnostic Testing Facility at Universal Ultrasound Diagnostics, shared a post on LinkedIn:
“Huge milestone for our team at ThinkSono: the FDA has granted clearance for ThinkSono Guidance.
It’s the first AI-powered ultrasound guidance software cleared for the evaluation of suspected deep vein thrombosis (DVT).
What this means in practice: a nurse or clinician with 60–90 minutes of training can capture a vascular ultrasound exam at the bedside, guided in real time by our AI, with every exam reviewed remotely by a qualified interpreting physician.
Faster answers for patients, wherever they present.
It took a decade of work, 1,691 patients across 24 study sites, and an incredible team to get here. Proud to be part of it!”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 12, 2026, 17:55Dries De Wolf: Honored to Have Wolfgang Miesbach Comment on Our Latest Research
-
Sep 12, 2026, 17:53Usman Waheed: Introducing the Discovery of the 49th ISBT Blood Group System
-
Sep 12, 2026, 17:51Maria Sabater Lleal: Happy to Share Our Latest Work Exploring the Genetic Determinants of PE in VTE
-
Sep 12, 2026, 17:51Jeff Sternlicht: Why LDL-C and ApoB Remain King of the Hill?
-
Sep 12, 2026, 17:49Kalyan Roy: TRAGS – An Emerging Transfusion Safety Concern
-
Sep 12, 2026, 17:48Jason Fung: What Happened to “Statins Save Lives”?
-
Sep 12, 2026, 17:47Eric Topol: Most Supplements and Vitamins Offer Little Proven Benefit
-
Sep 12, 2026, 17:44Manuel Monreal: Clinical Characteristics, Treatment, and Outcomes in Hispanic vs Caucasian Patients With VTE
-
Sep 12, 2026, 17:43Sidi Mohamed El Amine Benlazar: CPX-351 and Ruxolitinib in Advanced-Phase Myeloproliferative Neoplasms